Press Release – Charlie Gard: The End of Legal Proceedings
Press Statement: Charlie Gard – Doing The Right Thing For The Right Reasons (5 July 2017)The parents of Charlie Gard have ended their legal challenge to take their son to America for experimental “nucleoside” treatment. They now face what no parent ever wishes to face – the reality that there is no realistic medical hope that their little boy will recover.
A time will come to look at what went wrong in this case, why it was not possible to find agreement between parents and doctors about what was in Charlie’s best interests, and whether the legal case was decided rightly and on the right grounds. It might also become clearer in future whether this kind of experimental treatment could offer any hope to children with Charlie’s condition. However, these questions are for another day.
Now is the time to remember the preciousness of the child at the heart of this case, and to allow his parents to be with him until he passes from this life. If further treatment may no longer be worthwhile, Charlie’s life is inherently worthwhile, having the dignity and irreplaceability of every human life, and this will remain so even in the coming days. Charlie and all those around him remain in our thoughts and prayers at this time.
Most recent
Press Release – Essential Reading for World Suicide Prevention Day
10 September 2024
Today is World Suicide Prevention Day. Our Press Release draws attention to the publication of an im...
The Anscombe Centre mourns the death of Archbishop Noël Treanor
03 September 2024
The Staff and Governors of the Anscombe Bioethics Centre offer prayers and condolences for the death...
Baby loss: Grief, tears and dreams of Heaven
15 August 2024
In an article originally published in The Pastoral Review, the Centre’s Associate Research Fellow, D...
Support Us
The Anscombe Bioethics Centre is supported by the Catholic Church in England and Wales, Scotland, and Ireland, but has also always relied on donations from generous individuals, friends and benefactors.